Position in OGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,022,007
New position
Shares Held
170,619
first reported quarter
Ownership
0.065%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $52,277,450 across 13 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,771 | $15,317,921 | |
| 2 | ABBV |
AbbVie Inc.
|
47,682 | $11,998,698 | |
| 3 | JNJ |
Johnson & Johnson
|
35,531 | $9,023,808 | |
| 4 | MRK |
Merck & Co., Inc.
|
32,161 | $4,132,688 | |
| 5 | AMGN |
Amgen Inc
|
7,473 | $2,706,122 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,631 | $2,353,840 | |
| 7 | PFE |
Pfizer Inc
|
74,689 | $1,798,511 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
30,225 | $1,741,564 |
All Filings in OGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,022,007 | 170,619 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||